Holdings Channel
Play Video: The Importance of Insider Buying


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quotes delayed 20 minutes

Email EnvelopeFree CDXC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Other companies seeing insider buying close in time to when the ChromaDex Insider Buying occurred are:

Qorvo Insider Buying
Tandem Diabetes Care Insider Buying
T2 Biosystems Insider Buying
BIO-key International Insider Buying
1895 Bancorp of Wisconsin Inc (New) Insider Buying
Cyanotech Insider Buying
InspireMD Insider Buying
Ring Energy Insider Buying
Vital Energy Insider Buying
Telos (MD) Insider Buying

ChromaDex insider buying image
The table below summarizes the most recent ChromaDex insider buying information, with links below the price to see the CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more information about why ChromaDex insider buys are important for investors to follow.
DateInsiderPriceAmount
12-1-2023
Insider Buy
Brianna Gerber
Chief Financial Officer
$1.41
CAGR »
$7,050.00
5,000 shares
6-12-2023
Insider Buy
Frank L. Jaksch Jr.
Director
$1.69
CAGR »
$11,830.00
7,000 shares
5-25-2023
Insider Buy
Steven D. Rubin
Director
$1.46
CAGR »
$10,220.00
7,000 shares
9-30-2022
Insider Buy
Robert N. Fried
Cheif Executive Officer
$1.25
CAGR »
$100,000.00
80,000 shares
9-30-2022
Insider Buy
Hoi Shuen Solina Holly Chau
>10% Owner
$1.25
CAGR »
$1,200,000.00
960,000 shares
6-16-2022
Insider Buy
Hoi Shuen Solina Holly Chau
>10% Owner
$1.66
CAGR »
$99,877.55
60,037 shares
3-16-2022
Insider Buy
Robert N. Fried
CEO
$2.16
CAGR »
$54,000.00
25,000 shares
5-13-2021
Insider Buy
Robert N. Fried
CEO
$6.65
CAGR »
$66,500.00
10,000 shares
11-6-2020
Insider Buy
Kevin M. Farr
CHIEF FINANCIAL OFFICER
$4.43
CAGR »
$22,150.00
5,000 shares
5-19-2020
Insider Buy
Robert N. Fried
CEO
$4.69
CAGR »
$4,690.00
1,000 shares
11-14-2019
Insider Buy
Robert N. Fried
CEO
$3.09
CAGR »
$30,900.00
10,000 shares
8-23-2019
Insider Buy
Robert N. Fried
CEO
$4.03
CAGR »
$10,075.00
2,500 shares
5-21-2019
Insider Buy
Robert N. Fried
CEO
$4.43
CAGR »
$9,980.79
2,253 shares
3-15-2019
Insider Buy
Robert N. Fried
CEO
$3.80
CAGR »
$19,000.00
5,000 shares
3-14-2019
Insider Buy
Kevin M. Farr
CHIEF FINANCIAL OFFICER
$3.99
CAGR »
$26,832.75
6,725 shares
3-12-2019
Insider Buy
Kevin M. Farr
CHIEF FINANCIAL OFFICER
$3.62
CAGR »
$26,426.00
7,300 shares
3-11-2019
Insider Buy
Kevin M. Farr
CHIEF FINANCIAL OFFICER
$3.49
CAGR »
$19,893.00
5,700 shares
5-18-2018
Insider Buy
Kevin M. Farr
CHIEF FINANCIAL OFFICER
$3.83
CAGR »
$19,150.00
5,000 shares
5-15-2018
Insider Buy
Robert N. Fried
PRESIDENT, COO
$3.63
CAGR »
$36,300.00
10,000 shares
11-17-2017
Insider Buy
River Ventures Ltd Champion
>10% Owner
$4.10
CAGR »
$2,999,998.70
731,707 shares
8-25-2017
Insider Buy
Stephen R. Allen
$3.31
CAGR »
$6,620.00
2,000 shares
8-18-2017
Insider Buy
Step Holdings Ltd Pioneer
>10% Owner
$2.60
CAGR »
$2,044,034.20
786,167 shares
8-18-2017
Insider Buy
River Ventures Ltd Champion
>10% Owner
$2.60
CAGR »
$3,066,050.00
1,179,250 shares
5-24-2017
Insider Buy
Step Holdings Ltd Pioneer
>10% Owner
$2.60
CAGR »
$6,555,967.60
2,521,526 shares
5-24-2017
Insider Buy
River Ventures Ltd Champion
>10% Owner
$2.60
CAGR »
$9,833,948.80
3,782,288 shares
5-19-2017
Insider Buy
Stephen R. Allen
$3.20
CAGR »
$9,600.00
3,000 shares
3-20-2017
Insider Buy
Stephen R. Allen
$2.81
CAGR »
$5,620.00
2,000 shares
9-1-2016
Insider Buy
Robert N. Fried
$3.39
CAGR »
$50,850.00
15,000 shares
6-20-2016
Insider Buy
Troy Allen Rhonemus
CHIEF OPERATING OFFICER
$3.47
CAGR »
$27,083.60
7,800 shares

Also See: Institutional Holders of CDXC
Also See: SEC filings

CDXC Performance Since Insider Purchase
Below we present the annualized performance delivered by ChromaDex stock since 12-1-2023 (the date of the most recent insider purchase). The performance of the investment from the time ChromaDex insider buying occurred is the ultimate test of whether insiders were right about CDXC being a good buy.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 12/04/2023
End date: 04/25/2024
Start price/share: $1.40
End price/share: $3.39
Dividends collected/share: $0.00
Total return: 142.14%
Annualized Gain: 365.37%
Starting investment: $10,000.00
Ending investment: $24,214.00
Years: 0.39

ChromaDex Insider Buying

This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent ChromaDex insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).

Also See: Funds Holding CDXC

ChromaDex Insider Buying | www.HoldingsChannel.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in Holdings Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Holdings Channel; Meet Our Editorial Staff.